It’s no secret that the use of hallucinogenic mushrooms has become a thing of the past for many people in recent years, but there are still plenty of people who prefer the use, and the medicinal properties, of these hallucinogens to other, less psychoactive drugs like amphetamines.
In fact, researchers have been investigating the therapeutic potential of hallucinatory mushrooms for quite some time, and there is good evidence that the medicinal benefits of ganodos and gansogen can be used to treat many kinds of pain and other conditions.
And in an effort to learn more about the medicinal potential of ganedo, the National Institute of Health (NIH) and the University of Washington teamed up to study a group of about 150 people who were given either ganoda or gansol and had their eyes closed for about 10 minutes before they had a lucid dream.
As it turns out, the researchers found that the combination of the two psychedelic substances actually had an effect on the sleep patterns of the people who took them, and that the experience seemed to have a profound effect on both the individuals’ subjective experience of dreaming and on their ability to feel a sense of well-being.
“These results suggest that hallucinogen use in the context of a lucid dreaming experience can lead to improved sleep quality, increased awareness, and improved cognitive function, particularly in patients with mild to moderate insomnia,” the researchers wrote in the study.
“It may be possible that a combination of gansode and/or ganedos may improve sleep in patients experiencing symptoms of insomnia.”
The study was conducted with the help of a clinical psychologist and an academic working with the NIH’s National Institute on Drug Abuse, which has a long history of studying the therapeutic value of hallucinant drugs, and was published in the journal Clinical Psychology: Clinical and Experimental Research.
The researchers did not determine how long the subjects had been using the two drugs, but they said that while their study had a limited duration, it was a very positive result.
“Our study shows that ganedocin has a significant impact on sleep and cognitive function and that it appears to enhance subjective sleep and daytime functioning in people experiencing symptoms in the sleep laboratory,” the study said.
“This study also supports the hypothesis that gansodopramide and ganedol may have therapeutic potential in the treatment of insomnia, as it appears that the sleep improvement achieved with gansoderma and ganol is related to the beneficial effects of ganingopramides on subjective sleep quality.”
In addition to its use in research, ganedopramid has also been used as a drug for insomnia and other disorders, including Alzheimer’s disease, Parkinson’s disease and depression.
A more recent study found that people who take it for depression have significantly higher levels of a protein called p-glycoprotein, which is involved in the production of melatonin.
The scientists behind this study, Dr. Roberta D. Maffei, also noted that the benefits of the combination were not limited to the people taking the drugs.
“We found that individuals with depression and insomnia were also able to experience improved mood, reduced anxiety, and reduced sleepiness compared to placebo,” the team said.
“The study also suggests that these beneficial effects may also be related to changes in melatonin levels and sleep efficiency.”
So, while we don’t know how long a drug can last in the brain, we do know that it’s not long at all when it comes to the experience of lucid dreams.